时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
13:00-13:05 | 致辞 |
临床药理分会场开幕式 |
|
|||
13:05-13:35 | 专题报告 |
儿科疾病精准诊疗 |
|
|||
13:35-14:05 | 专题报告 |
“十四五”精准战略下的儿童用药与健康 |
|
|||
14:05-14:35 | 专题报告 |
对儿童百日咳再现的思索与对策 |
|
|||
14:35-14:40 | 讨论 |
集体答疑,讨论 |
||||
14:40-14:46 | 论文发言 |
Efficacy of clonidine adhesive patch on improving social function for children with Tourette syndrome:a randomized, double-blind,placebo-controlled, multicenter clinical trial |
|
|||
14:46-14:52 | 论文发言 |
支气管哮喘和或变应性鼻炎儿童进行皮下特异性免疫治疗发生全身不良反应的危险因素分析 |
|
|||
14:52-14:58 | 论文发言 |
医药转诊协作模式下的儿科药学门诊建设:循证、调研与实施 |
|
|||
14:58-15:04 | 论文发言 |
探讨妇儿弱势群体的数字化临床研究 |
|
|||
15:04-15:10 | 论文发言 |
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: A real-world pharmacovigilance analysis |
|
|||
15:10-15:16 | 论文发言 |
抽动障碍儿童的阿立哌唑代谢比与CYP2D6基因多态性关系及对剂量-暴露的影响 |
|
|||
15:16-15:22 | 论文发言 |
Effectiveness of adding heparin in parenteral nutrition to maintain peripherally inserted central catheter in preterm neonates: a 4 years retrospective cohort study |
|
|||
15:22-15:28 | 论文发言 |
肺炎支原体肺炎患儿气道黏液栓形成早期预测因子的研究 |
|
|||
15:28-15:33 | 讨论 |
集体答疑,讨论 |
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
15:33-16:03 | 专题报告 |
儿科药学服务—从国家中心到县域示范 |
|
|||
16:03-16:33 | 专题报告 |
模型引导的儿童抗感染个体化治疗 |
|
|||
16:33-16:38 | 讨论 |
集体答疑,讨论 |
||||
16:38-16:44 | 论文发言 |
Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations |
|
|||
16:44-16:50 | 论文发言 |
Clinical application value of pharmacokinetic parameters of vancomycin in children treated in the PICU |
|
|||
16:50-16:56 | 论文发言 |
细菌性脑膜炎合并肾功能亢进儿童的美罗培南药代动力学研究 |
|
|||
16:56-17:02 | 论文发言 |
Therapeutic drug monitoring for sirolimus in children with vascular anomalies: what can we learn from a retrospective study |
|
|||
17:02-17:08 | 论文发言 |
Analysis of influencing factors of serum concentration and efficacy of oxcarbazepine active metabolites in children with epilepsy: a single-center retrospective study |
|
|||
17:08-17:14 | 论文发言 |
他克莫司在肾病综合征儿童中的最佳谷浓度范围研究 |
|
|||
17:14-17:20 | 论文发言 |
外部验证支持下万古霉素群体药物动力学模型外推用于儿童患者模型引导的精准用药 |
|
|||
17:20-17:26 | 论文发言 |
A real-world study of the optimal cutoff value for vancomycin trough concentration associated with outcomes in children infected with Gram-positive bacteria |
|
|||
17:26-17:30 | 讨论 |
集体答疑、讨论 |